These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. An investigation into the mechanisms of the cardiovascular effects of 5-hydroxytryptamine in conscious normotensive and DOCA-salt hypertensive rats. Dalton DW, Feniuk W, Humphrey PP. J Auton Pharmacol; 1986 Sep; 6(3):219-28. PubMed ID: 3771594 [Abstract] [Full Text] [Related]
8. Enhanced contraction to 5-hydroxytryptamine is not due to "unmasking" of 5-hydroxytryptamine(1b) receptors in the mesenteric artery of the deoxycorticosterone acetate-salt rat. Banes AK, Watts SW. Hypertension; 2001 Oct; 38(4):891-5. PubMed ID: 11641304 [Abstract] [Full Text] [Related]
9. The cardiovascular effects of centrally administered 5-hydroxytryptamine in the conscious normotensive and hypertensive rat. Dalton DW. J Auton Pharmacol; 1986 Mar; 6(1):67-75. PubMed ID: 3957952 [Abstract] [Full Text] [Related]
10. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release. Chen YF, Jin HK, Paul R, Nagahama S. J Pharmacol Exp Ther; 1988 Aug; 246(2):485-92. PubMed ID: 2969976 [Abstract] [Full Text] [Related]
11. Studies on the mechanism of action of the hypotensive effect of ketanserin. Marwood JF, Stokes GS. Clin Exp Pharmacol Physiol; 1984 Aug; 11(2):125-32. PubMed ID: 6086191 [Abstract] [Full Text] [Related]
12. Serotonin-induced contraction in mesenteric resistance arteries: signaling and changes in deoxycorticosterone acetate-salt hypertension. Watts SW. Hypertension; 2002 Mar 01; 39(3):825-9. PubMed ID: 11897772 [Abstract] [Full Text] [Related]
13. 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats. Watts SW, Fink GD. Am J Physiol; 1999 Mar 01; 276(3):H944-52. PubMed ID: 10070078 [Abstract] [Full Text] [Related]
14. Ritanserin and serotonergic mechanisms in blood pressure and fluid regulation in sheep. Nelson M, Coghlan JP, Denton DA, Tresham JJ, Whitworth JA, Scoggins BA. Clin Exp Pharmacol Physiol; 1987 Jul 01; 14(7):555-63. PubMed ID: 3124998 [Abstract] [Full Text] [Related]
16. Vagal afferent-mediated inhibition of a nociceptive reflex by i.v. serotonin in the rat. II. Role of 5-HT receptor subtypes. Meller ST, Lewis SJ, Brody MJ, Gebhart GF. Brain Res; 1992 Jul 10; 585(1-2):71-86. PubMed ID: 1511336 [Abstract] [Full Text] [Related]
17. Vascular responsiveness to serotonin metabolites in mineralocorticoid hypertension. Thompson LP, Webb RC. Hypertension; 1987 Mar 10; 9(3):277-81. PubMed ID: 2434424 [Abstract] [Full Text] [Related]
18. The effects of ketanserin, methysergide and LY 53857 on sympathetic nerve activity. Ramage AG. Eur J Pharmacol; 1985 Jul 31; 113(3):295-303. PubMed ID: 2931285 [Abstract] [Full Text] [Related]
19. 19-Hydroxyandrostenedione amplifies the hypertensive action of mineralocorticoids in rats. Sekihara H, Yazaki Y, Kojima T. J Endocrinol; 1993 Jul 31; 138(1):31-40. PubMed ID: 7852890 [Abstract] [Full Text] [Related]